Literature DB >> 6143898

Neuroleptic malignant syndrome and hyponatraemia.

J A Wedzicha, B I Hoffbrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6143898     DOI： 10.1016/s0140-6736(84)92421-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Neuroleptic malignant syndrome associated with inappropriate antidiuresis and psychogenic polydipsia.

Authors:  C R Tomson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-18

Review 2.  Role of the intensive care unit in the management of the poisoned patient.

Authors:  P Kulling; H Persson
Journal:  Med Toxicol       Date:  1986 Sep-Oct

Review 3.  Clinical management of neuroleptic malignant syndrome.

Authors:  V L Susman
Journal:  Psychiatr Q       Date:  2001

4.  Neuroleptic malignant syndrome: a review.

Authors:  R A O'Brien; G B Young
Journal:  Can Fam Physician       Date:  1989-05       Impact factor: 3.275

Review 5.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

Review 6.  Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs.

Authors:  O Spigset; K Hedenmalm
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.